AI Product Menu
Robust AI-powered products for pathology assessment across research and clinical development.
Oncology
PathExploreTM
AI-powered panel of histopathology features that spatially characterizes the tumor microenvironment. Available in 8 cancer indications for biopharma research use.
Learn more about PathExplore
PathExplore is research use only. Not intended for diagnostic procedures.
AIM-PD-L1TM
Detect and quantify PD-L1+ tumor and immune cells. Available for biopharma and lab research use.
Indications and assay compatibility:
- Head and neck squamous cell carcinoma: 28-8
- Melanoma: 28-8
- Non-small cell lung cancer: 22C3, 28-8, SP263, and SP142
- Melanoma: 28-8
AIM-PD-L1 is research use only. Not intended for diagnostic procedures.
AIM-HER2TM Breast Cancer
Automated and reproducible digital HER2 scoring with explainable AI heatmap visualizations.
Learn more about AIM-HER2
AIM-HER2 is For Research Use Only. Not for use in diagnostic procedures.
NASH
AIM-NASHTM
Automated, reproducible, and validated AI-powered ordinal and continuous NASH CRN score component grades and fibrosis stage. Available for biopharma research use.
Learn more about AIM-NASH
AIM-NASH is research use only. Not intended for diagnostic procedures.
NASH ExploreTM
AI-powered panel of histopathology features that spatially characterizes the NASH tissue biopsy microarchitecture. Includes subtyping of fibrosis and landmark classification.
Learn more about NASH Explore
NASH Explore is research use only. Not intended for diagnostic procedures.
Inflammatory Bowel Disease
AIM-HITM Ulcerative Colitis
Automated and reproducible Geboes scoring, sub-category scoring, and conversion to Robarts and Nancy scoring for ulcerative colitis. Available for biopharma and lab research.
Learn More about AIM-HI UC
AIM-HI Ulcerative Colitis is research use only. Not intended for diagnostic procedures.
IBD ExploreTM
AI-powered panel of histopathology features that spatially characterizes the inflammatory microenvironment in ulcerative colitis. Available for biopharma research.
Learn more about IBD Explore
IBD Explore is research use only. Not intended for diagnostic procedures.
Delivering the highest quality algorithms
Data
Breadth (orthogonal data, outcomes) and depth (multiple scanners, stains, lab sources) to maximize predictive utility while minimizing bias.
Development & Evaluation
Optimal machine learning architecture (GNNs, Generative, End-to-End) and rigorous testing based on analytical goals and context of use.
Deployment
Integration into AISightTM platforms designed for use in translational research and clinical trials.
